News about Industrial talks

CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar

CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar

CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar

Industrial talks | 10/07/2023 | By Sudeep Soparkar 859

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

Industrial talks | 10/07/2023 | By Sudeep Soparkar 895

Teva mulls $2b sale of API activities

Teva mulls $2b sale of API activities

Teva mulls $2b sale of API activities

Industrial talks | 06/07/2023 | By Sudeep Soparkar 722

Syngene to acquire multi-modal facility from Stelis Biopharma Ltd

Syngene to acquire multi-modal facility from Stelis Biopharma Ltd

Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high speed, commercial scale, fill-finish unit

Industrial talks | 06/07/2023 | By Sudeep Soparkar 685

Anupam Rasayan signs Memorandum of Understanding (MoU) with 3xper Innoventure Limited, a technological collaboration for new age pharma molecules

Anupam Rasayan signs Memorandum of Understanding (MoU) with 3xper Innoventure Limited, a technological collaboration for new age pharma molecules

Anupam Rasayan signs Memorandum of Understanding (MoU) with 3xper Innoventure Limited, a technological collaboration for new age pharma molecules<br />

Industrial talks | 06/07/2023 | By Sudeep Soparkar 754

Lupin recast may demerge API business for unlocking value

Lupin recast may demerge API business for unlocking value

Lupin recast may demerge API business for unlocking value

Industrial talks | 27/06/2023 | By Sudeep Soparkar 667

Dr. Reddy's enters the trade generics business in India

Dr. Reddy's enters the trade generics business in India

Dr. Reddy's enters the trade generics business in India

Industrial talks | 26/06/2023 | By Sudeep Soparkar 330

Sanofi's Full Embrace of AI and Data Science to Accelerate Medical Breakthroughs for Patients

Sanofi's Full Embrace of AI and Data Science to Accelerate Medical Breakthroughs for Patients

Sanofi “all in” on artificial intelligence and data science to speed breakthroughs for patients

Industrial talks | 15/06/2023 | By Sudeep Soparkar 1443

IPA Set to Host 8th Global Pharmaceutical Quality Summit, Focusing on 'Patient Centricity - A New Manufacturing and Quality Paradigm

IPA Set to Host 8th Global Pharmaceutical Quality Summit, Focusing on 'Patient Centricity - A New Manufacturing and Quality Paradigm

IPA Set to Host 8th Global Pharmaceutical Quality Summit, Focusing on 'Patient Centricity - A New Manufacturing and Quality Paradigm

Industrial talks | 14/06/2023 | By Sudeep Soparkar 948

Aurobindo Pharma completes plant installation in China

Aurobindo Pharma completes plant installation in China

Aurobindo Pharma has completed the installation of its plant in China and is planning to commission it in the first quarter of next fiscal, said Santhanam Subramanian, Chief Financial Officer of the company.

Industrial talks | 07/06/2023 | By Sudeep Soparkar 1130

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members